Strengthen basic TB care to prevent the emergence of drug-resistance.
加强基本的结核治疗以预防出现耐药性。
Antibiotic use is half of the drug-resistance equation, however. The other half is controlling the bacteria that have already developed resistance.
然而，抗生素的使用仅仅是对付细菌耐药性工作的一半，另一半则是对已经有了抗药性的细菌的控制。
The European Union banned routine use of antibiotics in animal feed years ago because of evidence about its drug-resistance consequences for humans.
因为有证据表明细菌的抗药性可能传递到人类，欧盟约于数年前已经停止在动物饲养中抗诉素的常规使用。
The objective is to explore the role of efflux pump in drug resistance to fluoroquinolones in Stenotrophomonas maltophilia.
目的是探讨外排泵在嗜麦芽窄食单胞菌中对氟喹诺酮类药物的耐药性中的作用。
The objective is to test various biochemistrical characteristics, toxin and drug resistance of the Corynebacterium diphtheriae.
目的是要测试白喉棒状杆菌的各种生物化学特性、毒素和耐药性。
This experience underscores the need to protect the effectiveness of these drugs by minimizing the occurrence and impact of drug resistance.
这一经验强调需要保护这些药物的有效性，最大限度地减少耐药的发生和带来的影响。
Since 1994, only 59% of all countries globally have been able to collect high quality representative data on drug resistance.
自1994年以来，全球所有国家中，只有59%都能够收集高质量有代表性的耐药监测数据。
Drug resistance costs vast amounts of money, and affects vast Numbers of lives. The trends are clear and ominous.
耐药造成了巨大的经济损失，众多人的生命受到影响，这种不祥的趋势显而易见。
WHO recommends the routine monitoring of antimalarial drug resistance, and supports countries to strengthen their efforts in this important area of work.
世卫组织建议常规监测对抗疟药物的耐药性，并协助各国努力加强在这一重要领域的工作。
These practices must be prevented as they hasten the development of drug resistance. They also undermine good overall malaria control.
必须制止这种做法，因为这种做法会加快耐药性的产生，也会破坏良好的整体疟疾控制。
With such broad and regular use of the drug over the years monitoring drug resistance is essential to ensure ongoing worm control success.
由于在过去数年内大范围惯常使用此药，为确保正在进行的蠕虫控制工作取得成功，必需监测耐药发生情况。
This report presents drug resistance data from 114 countries and updated information from 35 of them.
该报告提供了114个国家的耐药性数据和其中35个国家的最新信息。
Antimalarial drug resistance is like a cancer, it must be fought at every level - affected countries need to be in the frontline in combating the emergence of drug resistance.
抗疟药物耐药性就象癌症，必须在每一层面上开展斗争—受影响的国家需要站在第一线，抵御耐药性的出现。
The relatively poor outcomes in these two regions can be attributed, in part, to the complications of HIV coinfection and drug resistance, respectively.
造成这两个区域治疗成功率不佳的部分原因分别是艾滋病毒合并感染的并发症和抗药性。
Faulty practices and flawed assumptions have clearly made the inevitable development of drug resistance happen much sooner, rather than later.
耐药性迟早都会出现，而错误的做法和站不住脚的假设明显地让它提前发生，而非延后。
Since the World Health Organization (WHO) began systematically surveying drug resistance to tuberculosis treatments in 1994, it has observed a continual increase in drug resistance.
自世界卫生组织1994年开始系统调查结核病治疗的耐药性情况以来，已注意到耐药性在持续增加。
He refused to give an exact proportion of patients who had developed drug resistance, saying the statistics are still being checked and evaluated.
他没有给出出现耐药性情况患者的准确比例，说该数据还需要继续检测和估计。
Since 2009, the 23 countries most heavily affected by TB drug resistance have nearly doubled their budgets for MDR-TB.
自2009年以来，受到耐药结核病影响最重的23个国家已经将用于耐多药结核病的预算几近翻番。
Health specialists say drug resistance to existing malaria treatment has emerged as a serious problem in some parts of the country.
卫生专家们表示，现有的治疗方法已出现了抗药的情况，在该国的有些地区，这已经成为一个严重的问题。
Drug resistance costs vast amounts of money, and affects vast Numbers of lives.
耐药性会耗费大量金钱并影响众多生命。
Last year, the WHO report on anti-TB drug resistance documented the highest levels of multi-drug resistance ever recorded in a general population.
去年世卫组织抗结核耐药报告说明了在一般人群中结核病耐多药情况已达到前所未有的最高水平。
Our research shows drug resistance is not confined to hospitals, but is out in the community.
我们的研究表明，抗药性并不局限于医院，而是在整个环境。
This experience further underscores the need to protect the effectiveness of these drugs by minimizing the occurrence and impact of drug resistance.
这方面的经验进一步证实，需要尽量减少耐药性的发生及其影响，以维护这些药物的疗效。
But when it comes to fighting drug resistance, the more targets we go after the better, he adds.
但是当谈到对付细菌抗药性时，他补充说，我们追求的目标越多越好。
This improves cure rates and reduces risks of drug resistance development.
这提高了治愈率，降低了耐药性加剧的风险。
WHO recommends that countries use a combination of antimalarial medicines to reduce the risk of drug resistance.
世卫组织建议各国使用抗疟联合药物以减少产生抗药性的危险。
Better diagnostic tools contribute to the more rational use of drugs, and this helps delay the development of drug resistance.
更好的诊断工具可促进更合理的药物使用，从而有助于推迟形成耐药性。
Better diagnostic tools contribute to the more rational use of drugs, and this helps delay the development of drug resistance.
更好的诊断工具可促进更合理的药物使用，从而有助于推迟形成耐药性。
应用推荐